HYPERTENSIVE CARDIOMYOPATHY

This adverse event was reported 278 times

These drugs are most commonly taken by patients reporting HYPERTENSIVE CARDIOMYOPATHY:

# Drug Count
0 OMEPRAZOLE MAGNESIUM 26
1 OMEPRAZOLE 24
2 FUROSEMIDE 22
3 METHOTREXATE SODIUM 22
4 CYCLOSPORINE 21
5 METHOTREXATE 20
6 TOCILIZUMAB 20
7 TOFACITINIB CITRATE 20
8 VALSARTAN 20
9 ANAKINRA 19
See all common drugs associated with HYPERTENSIVE CARDIOMYOPATHY

HYPERTENSIVE CARDIOMYOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CAFFEINE, MAGNESIUM SALICYLATE 1 0.0039
1 MEPROBAMATE 4 0.0031
2 PAMABROM 1 0.0027
3 IMIPRAMINE HYDROCHLORIDE 1 0.0018
4 CANAKINUMAB 19 0.0017
5 BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE 1 0.0016
6 CHLOROQUINE PHOSPHATE 1 0.0015
7 TOFACITINIB CITRATE 20 0.0015
8 TEDIZOLID PHOSPHATE 1 0.0012
9 ANAKINRA 19 0.0011
See all drugs enriched for association with HYPERTENSIVE CARDIOMYOPATHY

HYPERTENSIVE CARDIOMYOPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-1 Receptor Antagonist [EPC] 19 0.0011
1 Vitamin D2 Analog [EPC] 8 0.0011
2 alpha-1 Adrenergic Agonist [EPC] 2 0.0005
3 Vitamin D Analog [EPC] 8 0.0004
4 Antihypoglycemic Agent [EPC] 1 0.0002
5 Vitamin K [EPC] 2 0.0002
6 Blood Viscosity Reducer [EPC] 1 0.0002
7 Androgen [EPC] 6 0.0002
8 Calcineurin Inhibitor Immunosuppressant [EPC] 21 0.0002
9 Cardiac Glycoside [EPC] 11 0.0002
See all drug classes enriched for association with HYPERTENSIVE CARDIOMYOPATHY